2022 Healthcare Medical science 
PM360
NOVEMBER 29, 2022
Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. At the same time, MSLs are being asked to help inform brand strategy with their learnings from talking to leading healthcare professionals.
MaBiCo
JANUARY 21, 2025
It is worth noting that in the entire human history until 2022, science had discovered a total of about 190,000 different proteins. As mentioned above, in 2022 DeepMinds AlphaFold 2 discovered over 200 million proteins, which were made freely available to researchers. appeared first on MaBiCo.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Clarivate
MARCH 8, 2023
In recent years, there has been an increased focus on real world evidence to advance medical science and improve patient quality of life. The Professional Society for Health Economics and Outcomes Research (ISPOR) has cited real world evidence (RWE) as the number one trend in healthcare decision making for the second year running [1].
pharmaphorum
DECEMBER 23, 2022
In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). Seamless data sharing between clinical teams and medical science liaisons, for example, could greatly influence clinical trial site selection and ensure more coordinated engagement.
PM360
DECEMBER 20, 2024
When the first biosimilars were approved by the FDA almost a decade ago, they were expected to provide a cost-effective alternative to expensive biologics, improve accessibility for patients and reduce healthcare spending by creating competition in the biologic market. So, that’s quite the hurdle for access, I think.
European Pharmaceutical Review
FEBRUARY 22, 2023
1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. 2022 [cited 2023Feb]. No serious adverse events were reported.
PM360
SEPTEMBER 15, 2022
Heavy patient loads, paperwork, research, presentations at medical meetings, and department/academic obligations make it tough to keep up with the literature, new therapies, and understanding of how community level and peers manage their patients. Healthcare professionals (HCPs) are changing their habits accordingly.
Expert insights. Personalized for you.
95 
Let's personalize your content